Connect Biopharma Holdings (CNTB) Change in Account Payables (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Change in Account Payables of $2.3 million for Q1 2026, up 7906.67% sequentially from -$30000.0 in Q4 2025, and up 393.05% YoY from $475000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Change in Account Payables (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Change in Account Payables for 3 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Change in Account Payables rose 393.05% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 678.79% YoY) and the FY2025 annual result came in at $1.6 million, up 186.88% from the prior year.
- Change in Account Payables improved to $2.3 million in Q1 2026 per CNTB's latest filing, from -$30000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.3 million in Q1 2026 and troughed at -$1.8 million in Q1 2024.
- A 3-year average of $233000.0 and a median of -$30000.0 in 2025 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 817.39% in 2025, down 104.08% in 2025.
- Over 3 years, Change in Account Payables stood at -$41000.0 in 2024, then gained by 26.83% to -$30000.0 in 2025, then soared by 7906.67% to $2.3 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $2.3 million, -$30000.0, and -$300000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.29 Mn |
| Jun 30, 2026 | -2.29 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | -30,000.00 |
| Dec 31, 2025 | -30,000.00 |
| Sep 30, 2025 | -300,000.00 |
| Sep 30, 2025 | -300,000.00 |
| Jun 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 475,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Jun 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 161,000.00 |
| Mar 31, 2024 | -1.84 Mn |
| Mar 31, 2024 | -1.84 Mn |